Lineage Cell Therapeutics Inc (NY: LCTX )
1.280 -0.040 (-3.03%) Official Closing Price Updated: 6:30 PM EDT, Jun 5, 2023 Add to My Watchlist
All News about Lineage Cell Therapeutics Inc
Lineage Cell Therapeutics: Q1 Earnings Insights
May 11, 2023
Preview: Lineage Cell Therapeutics's Earnings
March 08, 2023
EXCLUSIVE: Lineage Cell Inks Exclusive Agreement For Novel Cell-Based Therapies With Potential In Neurology
February 22, 2023
Lineage Cell Therapeutics Inc (NYSE: LCTX) has entered into an exclusive option and license agreement with Eterna Therapeutics Inc for beta 2 microglobulin (B2M)-deficient induced pluripotent stem cell...
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following